Device New Sbu Coded Detected!

Profusion Therapeutic Infusion Needle

Payments companies reported to CMS as associated with Profusion Therapeutic Infusion Needle. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$15Kassociated payments (2023-2025)
42clinicians with associated payments
2companies reporting

By year

2023 $2,422
2024 $2,313
2025 $10K

Payments reported as associated with Profusion Therapeutic Infusion Needle, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $8,486
Pediatric Cardiology $2,493
Urology $1,933
Diagnostic Radiology $859
Vascular Surgery $634
Pediatric Orthopaedic Surgery $297

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Profusion Therapeutic Infusion Needle

These are the largest totals companies reported as associated with Profusion Therapeutic Infusion Needle. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Venkatesh Krishnasamy Birmingham, AL Vascular & Interventional Radiology $6,516.54
Aimee Armstrong Columbus, OH Pediatric Cardiology $2,168.80
Paul Timperman West Lafayette, IN Vascular & Interventional Radiology $1,311.92
Paul Gagne Darien, CT Vascular Surgery $526.85
Ameet Patel Scottsdale, AZ Diagnostic Radiology $409.06
Surendranath Reddy Flushing, NY Pediatric Orthopaedic Surgery $297.07
David Woodrum Rochester, MN Diagnostic Radiology $249.38
Kush Desai Chicago, IL Vascular & Interventional Radiology $213.01
Sadeer Alzubaidi Scottsdale, AZ Diagnostic Radiology $167.78
Mitra De Cogain Rochester, MN Urology $153.84

Prescribed Profusion Therapeutic Infusion Needle?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.